Jump to content

Vas Narasimhan

The neutral encyclopedia of notable people
Vas Narasimhan
Narasimhan in 2022 (or earlier)
Vas Narasimhan
BornVasant Kalathur Narasimhan
8/26/1976
BirthplacePittsburgh, Pennsylvania, U.S.
NationalityAmerican
OccupationPhysician, business executive
TitleChief Executive Officer of Novartis
EducationUniversity of Chicago (BA)
Harvard Medical School (MD)
John F. Kennedy School of Government (MPP)
Children2
AwardsFortune 40 Under 40 (2015)
TIME100 Health (2025)
Websitehttps://www.novartis.com/about/executive-committee/vasant-narasimhan

[1] Joseph Jimenez.[2] Donald Trump [3] [1] [4] [5] [6] The Lancet'[7][8] [1] Doctor of Medicine Master of Public Policy [1][4] [6] [1][2] [1] Novartis Vaccines,[1][2] [9][10]Joseph Jimenez,[11][12]Avidity Biosciences,[13][14][15][16]World Economic Forum [17]White House [18]Economic Times'[19][20][21][22]World Economic Forum,[23]Andrew Mason Mark Cuban Chris Deluzio George Shiras Jr. Jim Taiclet Rand Paul

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 "CV – Vasant Narasimhan". Novartis. Retrieved 2026-02-24.
  2. ↑ 2.0 2.1 2.2 "Novartis Names Narasimhan CEO After Jimenez Retires Next Year". Bloomberg News. 2017-09-04. Retrieved 2026-02-24.
  3. ↑ "Trump meets Novartis CEO, says drugmaker building 11 US plants". Reuters. 2026-02-20. Retrieved 2026-02-24.
  4. ↑ 4.0 4.1 "Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis". Business Standard. 2017-09-04. Retrieved 2026-02-24.
  5. ↑ "Vas Narasimhan". TIME. 2025-05-08. Retrieved 2026-02-24.
  6. ↑ 6.0 6.1 "Novartis CEO Vas Narasimhan: Drawn to Analytics, Grounded Expectations for AI". Timmerman Report. 2025-09-05. Retrieved 2026-02-24.
  7. ↑ "Published research article". The Lancet / ScienceDirect. Retrieved 2026-02-24.
  8. ↑ "PubMed record". National Library of Medicine. Retrieved 2026-02-24.
  9. ↑ "Vas Narasimhan". Pharmaceutical Executive. Retrieved 2026-02-24.
  10. ↑ "Vas Narasimhan – Fortune 40 Under 40 (2015)". Fortune. Retrieved 2026-02-24.
  11. ↑ "CNBC Transcript: Vasant Narasimhan, CEO, Novartis". CNBC. 2018-03-26. Retrieved 2026-02-24.
  12. ↑ "Novartis CEO Steers Drug Maker Back to R&D". The Wall Street Journal. 2018-02-18. Retrieved 2026-02-24.
  13. ↑ "Novartis CEO paid top dollar for Avidity to become a 'leader in neuromuscular diseases'". Fierce Biotech. 2025-11-20. Retrieved 2026-02-24.
  14. ↑ "Novartis CEO pay soars 30% to $32M following record-breaking 2025 performance". Fierce Pharma. 2026-02-10. Retrieved 2026-02-24.
  15. ↑ "Novartis CEO projects 2026 growth despite 'largest patent expiry' in company history". Fierce Pharma. 2026-02-03. Retrieved 2026-02-24.
  16. ↑ "Novartis CEO Says Trump's Drug Pricing Deals Don't Address Root Problem". BioSpace. 2025-10-28. Retrieved 2026-02-24.
  17. ↑ "Watch Novartis CEO Vas Narasimhan on Drug Pricing, Trade, Jobs". Bloomberg. 2026-01-20. Retrieved 2026-02-24.
  18. ↑ "BBC News coverage of Novartis during COVID-19". BBC News. 2020-03-20. Retrieved 2026-02-24.
  19. ↑ "There's an explosion of data, digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis". The Economic Times. 2018-08-23. Retrieved 2026-02-24.
  20. ↑ "Weddings/Celebrations; Srishti Gupta, Vasant Narasimhan". The New York Times. 2003-03-16. Retrieved 2026-02-24.
  21. ↑ "Vasant Narasimhan – Executive Committee". Novartis. Retrieved 2026-02-24.
  22. ↑ "Vas Narasimhan, Novartis – Corner Office". The New York Times. 2019-08-01. Retrieved 2026-02-24.
  23. ↑ "Vasant Narasimhan – Agenda Contributor". World Economic Forum. Retrieved 2026-02-24.